journal
https://read.qxmd.com/read/38728930/unilateral-cortical-autoimmune-encephalitis-a-case-series-and-comparison-to-late-onset-rasmussen-s-encephalitis
#41
COMPARATIVE STUDY
Sophia Damman, Persen Sukpornchairak, Amit Ahituv, Alex Chen, David Wang, Komal Sawlani, Claude Steriade, Hesham Abboud
OBJECTIVE: To report a novel anatomical pattern of autoimmune encephalitis characterized by strictly unilateral cortical inflammation and a clinical picture overlapping with late-onset Rasmussen's encephalitis. METHODS: We retrospectively gathered data of patients identified at two tertiary referral academic centers who met inclusion criteria. RESULTS: We identified twelve cases (average age 65, +/- 19.8 years, 58% female). All patients had unilateral cortical inflammation manifesting with focal seizures, cognitive decline, hemicortical deficits, and unilateral MRI and/or EEG changes...
June 15, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38723578/immune-dysregulation-in-chronic-inflammatory-demyelinating-polyneuropathy
#42
JOURNAL ARTICLE
Yingkai Li, John S Yi, Jeffrey T Guptill, Vern C Juel, Lisa Hobson-Webb, Shruti M Raja, Tabitha Karatz, Karissa L Gable
OBJECTIVE: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder of the peripheral nerves with an incompletely understood underlying pathophysiology. This investigation focused on defining B and T cell frequencies, T cell functional capacity and innate immune system analysis in patients with CIDP. METHODS: By using multi-parameter flow cytometry, we examined the phenotype and function of PBMCs in 25 CIDP patients who were relatively clinically stable on treatment who met EFNS/PNS criteria, 21 patients with genetically confirmed hereditary neuropathy and 25 healthy controls...
June 15, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38897089/targeting-vegf-mediated-blood-brain-barrier-disruption-in-advanced-cerebral-leukodystrophy
#43
JOURNAL ARTICLE
Ashish O Gupta, Justin W Furcich, David R Nascene, Stephan Kemp, Carina J King, Erin E Nolan, Willa Durose, Bradley S Miller, Paul J Orchard, Troy C Lund
The earliest clinical manifestation of cerebral adrenoleukodystrophy (CALD) is adrenal insufficiency (AI) characterized by elevations in ACTH and loss of cortisol. We showed high (though physiologically achievable) levels of ACTH increases endothelial permeability, increases anisotropy, and increases VEGF secretion. An ACBD1 knockout endothelial cell line had increased sensitivity to ACTH and VEGF. Inhibition of VEGF via application of anti-VEGF (bevacizumab) improved permeability. Six boys with advanced CALD were treated with bevacizumab combined with dexamethasone and ruxolitinib as immune suppressants...
June 13, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38878600/xmen-disease-caused-by-the-novel-magt1-p-trp136-mutation-may-present-with-neuropsychiatric-symptoms
#44
JOURNAL ARTICLE
Henry Villenheimo, Virpi Glumoff, Sami Räsänen, Airi Jartti, Harri Rusanen, Pirjo Åström, Outi Kuismin, Timo Hautala
BACKGROUND: X-linked MAGT1 deficiency with increased susceptibility to EBV-infection and N-linked glycosylation defect (XMEN) disease is caused by MAGT1 loss-of-function (LOF) mutations. The disease commonly presents with respiratory symptoms. Although the central nervous system can be affected, the spectrum of neuropsychiatric symptoms is not completely understood. CASES: We describe a XMEN disease family presenting with atypical neuropsychiatric symptoms. The index, a previously healthy male, developed schizophrenia...
June 5, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38852213/spinocerebellar-ataxia-masquerading-as-multiple-sclerosis-a-case-report
#45
LETTER
Darla Wheeler, Mariam Bezih, Nicholas Lannen
No abstract text is available yet for this article.
June 4, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38850673/soluble-adhesion-molecules-cognitive-worsening-biomarkers-in-primary-progressive-multiple-sclerosis
#46
JOURNAL ARTICLE
Heather Y F Yong, Nicholas J Batty, Isabelle Tottenham, Marcus Koch, Carlos R Camara-Lemarroy
No abstract text is available yet for this article.
June 3, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/39032452/infection-vaccination-and-narcolepsy-type-1-evidence-and-potential-molecular-mechanisms
#47
JOURNAL ARTICLE
Ikram Ayoub, Sean A Freeman, Abdelhadi Saoudi, Roland Liblau
NT1 is a rare, chronic and disabling neurological disease causing excessive daytime sleepiness and cataplexy. NT1 is characterized pathologically by an almost complete loss of neurons producing the hypocretin (HCRT)/orexin neuropeptides in the lateral hypothalamus. While the exact etiology of NT1 is still unknown, numerous studies have provided compelling evidence supporting its autoimmune origin. The prevailing hypothetical view on the pathogenesis of NT1 involves an immune-mediated loss of HCRT neurons that can be triggered by Pandemrix® vaccination and/or by infection in genetically susceptible patients, specifically carriers of the HLA-DQB1*06:02 MHC class II allele...
June 1, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38850674/neurotropic-murine-coronavirus-mediated-demyelination-factors-dampening-pathogenesis
#48
JOURNAL ARTICLE
Mihyun Hwang, Cornelia C Bergmann
Virus infections and autoimmune responses are implicated as primary triggers of demyelinating diseases. Specifically, the association of Epstein-Barr virus (EBV) infection with development of multiple sclerosis (MS) has re-ignited an interest in virus induced autoimmune responses to CNS antigens. Nevertheless, demyelination may also be caused by immune mediated bystander pathology in an attempt to control direct infection in the CNS. Tissue damage as a result of anti-viral responses or low level viral persistence may lead to immune activation manifesting in demyelinating lesions, axonal damage and clinical symptoms...
June 1, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38823119/identification-of-rare-variants-in-the-fbxo38-gene-of-patients-with-chronic-inflammatory-demyelinating-polyradiculoneuropathy
#49
JOURNAL ARTICLE
Antoine Pegat, Jean-Baptiste Chanson, Pierre Lozeron, Bastien Joubert, Alexandre Bani-Sadr, Isabelle Quadrio, Léo Vidoni, Philippe Latour
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare immune-mediated neuropathy for which there is no clearly identified risk factor. The present study identified rare variants in the FBXO38 gene in three familial cases of CIDP with response to corticosteroids in three generations with incomplete penetrance, and in an unrelated fourth case with diffuse nerve hypertrophy. FBXO38 may be involved in the regulation of the immunity mediated by CD8 T cells, which have an important role in CIDP pathophysiology, through PD1 degradation...
May 28, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38797060/neuroinflammation-neurodegeneration-and-alteration-of-spatial-memory-in-balb-c-mice-through-ampicillin-induced-gut-dysbiosis-nos2-and-nfl-involvement-in-a-microbiota-gut-brain-axis-model
#50
JOURNAL ARTICLE
Nassima Behairi, Arezki Samer, Lynda Sahraoui, Djehane Houria Mataam, Ryad Trari, Billel Flissi, Houda Belguendouz, Zine-Charaf Amir, Chafia Touil-Boukoffa
We aimed to investigate ampicillin (AMP) mechanisms in microbiota-gut-brain axis. We evaluated its effect on two gut and brain regions and behavioral performances. We administred AMP (1 g/l) to BALB/c mice for 21 days. Then, we analyzed body weigth change, stool consistency scoring, gut length, intestinal microbiota composition, nitric oxide synthase 2 (NOS2) expression and tissue integrity. We subsequently evaluated NOS2, GFAP, CD68 and NFL cerebral expression and spatial memory.Interestingly, our data showed gut microbiota disruption, NOS2 upregulation and tissue damage, associated to cerebral NOS2, GFAP, CD68 and NFL over-expression and behavioral alteration...
May 20, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38788317/attenuated-adiponectin-omentin-increased-interleukin-6-and-tumor-necrosis-factor-alpha-levels-with-altered-cognition-and-depression-in-non-hodgkin-lymphoma-patients-a-case-control-study
#51
JOURNAL ARTICLE
Meghavi Kathpalia, Pinki Mishra, Afsha Majid, Mohd Ashif Khan, Anurag Sharma, Dinesh Bhurani, Nidhi
BACKGROUND AND PURPOSE: Immune dysfunction is one of the risk factors which plays an important role in the development of non-Hodgkin lymphoma (NHL), and inflammation may be involved in its etiology. Minimal data is available on the effect of cytokine levels on neurobehavioral function in lymphoma before the initiation of chemotherapy. Therefore, we aimed to explore the risk of NHL by assessment of cytokine and adipokine levels and their correlation with neurobehavioral changes. METHODS: This case-control study enrolled 62 subjects (age-sex matched: 31 cases and 31 controls)...
May 19, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38788318/targeted-desumoylation-as-a-therapeutic-strategy-for-multiple-sclerosis
#52
REVIEW
S Sriram, Kwang Woon Kim, Åsa Ljunggren-Rose
SUMO (small ubiquitin like modifier) conjugated proteins have emerged as an important post translational modifier of cellular function. SUMOylation modulates several cellular processes involved in transcriptional regulation of genes, protein-protein interactions and DNA damage and repair. Since abnormalities in SUMOylation has been observed in neoplastic and neurodegenerative disorders, the SUMO pathway has become an attractive site for targeting of new therapies to regulate SUMOylation and reduce disease burden...
May 18, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38776710/tenascin-c-in-patients-with-central-nervous-system-infections
#53
JOURNAL ARTICLE
Morten Zachariassen, Martin Munthe Thomsen, Thore Hillig, Pelle Trier-Petersen, Andreas Vestergaard Jensen, Lennart Jan Friis-Hansen, Christian Thomas Brandt
BACKGROUND: The extracellular matrix protein tenascin-C has been discovered to be an important regulator of the response to tissue injury and repair in cerebrovascular diseases. This study investigated if tenascin-C is released in response to infections in the central nervous system (CNS). METHODS: Tenascin-C concentration in the cerebrospinal fluid (CSF) was measured in patients, (>18 years) with and without CNS infections, admitted to a department of infectious diseases in Denmark...
May 15, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38648696/corticospinal-tract-hyperintensity-in-patients-with-lgi1-antibody-encephalitis-and-other-central-nervous-system-disorders-with-neuroglial-antibodies
#54
JOURNAL ARTICLE
Lucia Campetella, Macarena Villagrán-García, Antonio Farina, Marie Benaiteau, Raffaele Iorio, Paolo Calabresi, Alberto Vogrig, Salvatore Versace, Nicolás Lundahl Ciano-Petersen, Elodie Bicilli Brotelle, Pierre Branger, Clotilde Verlut, Sophie Langner-Lemercier, Alexandre Leclancher, Coline Duwicquet, Mahmoud Charif, Philippe Kerschen, Nicolas Capet, Dimitri Renard, Eve Chanson, Marie Rafiq, Louise Tyvaert, Bastien Joubert, François Cotton, Jérôme Honnorat, Sergio Muñiz-Castrillo
The frequency of corticospinal tract (CST) T2/FLAIR hyperintensity in disorders with neuroglial antibodies is unclear. Herein, we retrospectively reviewed brain MRIs of 101 LGI1-antibody encephalitis patients, and observed CST hyperintensity in 30/101 (30%). It was mostly bilateral (93%), not associated with upper motor neuron signs/symptoms (7%), and frequently decreased over time (39%). In a systematic review including patients with other neuroglial antibodies, CST hyperintensity was reported in 110 with neuromyelitis optica (94%), myelin oligodendrocyte glycoprotein-associated disease (2%), Ma2-antibody (3%) and GAD65-antibody paraneoplastic neurological syndrome (1%)...
May 15, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38640827/microglia-and-amyloid-plaque-formation-in-alzheimer-s-disease-evidence-possible-mechanisms-and-future-challenges
#55
REVIEW
Stefanie Fruhwürth, Henrik Zetterberg, Søren R Paludan
Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive decline that severely affects patients and their families. Genetic and environmental risk factors, such as viral infections, synergize to accelerate the aging-associated neurodegeneration. Genetic risk factors for late-onset AD (LOAD), which accounts for most AD cases, are predominantly implicated in microglial and immune cell functions. As such, microglia play a major role in formation of amyloid beta (Aβ) plaques, the major pathological hallmark of AD...
May 15, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38554666/recent-advances-in-the-treatment-of-primary-and-secondary-progressive-multiple-sclerosis
#56
REVIEW
Shitiz Sriwastava, Mahmoud Elkhooly, Suban Amatya, Kriti Shrestha, Yusuf Kagzi, Dipika Bhatia, Rajesh Gupta, Shruti Jaiswal, Robert P Lisak
BACKGROUND: The article highlights upcoming potential treatments, which target different phases of inflammation and offer remyelinating strategies as well as direct and indirect neuroprotective and oligodendrocyte protective effects, providing a hopeful outlook for patients with primary and secondary progressive multiple sclerosis (PPMS and SPMS). OBJECTIVES: The review aims to identify potential treatments and ongoing clinical trials for PPMS and SPMS, and compare their mechanisms of action, efficacy, and side effects with current treatments...
May 15, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38823118/electroconvulsive-therapy-in-n-methyl-d-aspartate-receptor-encephalitis-a-retrospective-cohort-and-scoping-review-of-literature
#57
REVIEW
Melissa A Wright, Mar Guasp, Christian Lachner, Gregory S Day, Grace Gombolay, Maarten J Titulaer, Stacey L Clardy
Neuropsychiatric symptoms in N-methyl-d-aspartate receptor encephalitis (NMDARE) have led some to pursue empiric trials of electroconvulsive therapy (ECT). A scoping review identified 39 patients diagnosed with NMDARE undergoing ECT. Separately, a retrospective cohort was reviewed to characterize 21 patients. Clinical improvement was attributed to ECT in 49% of patients in the scoping review and 19% of patients in the retrospective cohort; timing of immunotherapies was a confounding factor. Worsening of clinical course following ECT was reported in 28% of patients in the scoping review and 38% of patient in the retrospective review...
May 14, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38735091/early-hyperbaric-oxygen-therapy-through-regulating-the-hif-1%C3%AE-signaling-pathway-attenuates-neuroinflammation-and-behavioral-deficits-in-a-mouse-model-of-sepsis-associated-encephalopathy
#58
JOURNAL ARTICLE
Yan Wang, Ping Ni, Dongmei Zhuang, Peng Zhou, Furong Zhu, Danqiao Yin, Rui Zhu, Bin Mei, Shaohua Hu
BACKGROUND: Sepsis-associated encephalopathy (SAE) presents a significant clinical challenge, associated with increased mortality and healthcare expenses. Hyperbaric oxygen therapy (HBOT), involving inhaling pure or highly concentrated oxygen under pressures exceeding one atmosphere, has demonstrated neuroprotective effects in various conditions. However, the precise mechanisms underlying its protective actions against sepsis-associated brain injury remain unclear. This study aimed to determine whether HBOT protects against SAE and to elucidate the impact of the hypoxia-inducible factor-1α (HIF-1α) signaling pathway on SAE...
May 7, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38733741/lipid-metabolism-is-dysregulated-in-endocrine-glands-upon-autoimmune-demyelination
#59
JOURNAL ARTICLE
Jonathan J Carver, Bryce A Pugh, Kristy M Lau, Alessandro Didonna
Disturbance in neuroendocrine signaling has been consistently documented in multiple sclerosis (MS), a chronic autoimmune disorder of the central nervous system (CNS) representing the main cause of non-traumatic brain injury among young adults. In fact, MS patients display altered hormonal levels and psychiatric symptoms along with the pathologic hallmarks of the disease, which include demyelination, neuroinflammation and axonal injury. In addition, we have recently shown that extensive transcriptional changes take place in the hypothalamus of mice upon the MS model experimental autoimmune encephalomyelitis (EAE)...
May 7, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38723577/aflatoxin-b-1-exposure-deteriorates-immune-abnormalities-in-a-btbr-t-itpr3-tf-j-mouse-model-of-autism-by-increasing-inflammatory-mediators-production-in-cd19-expressing-cells
#60
JOURNAL ARTICLE
Taghreed N Almanaa, Mohammad Y Alwetaid, Saleh A Bakheet, Sabry M Attia, Mushtaq A Ansari, Ahmed Nadeem, Sheikh F Ahmad
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficiencies in communication, repetitive and stereotyped behavioral patterns, and difficulties in reciprocal social engagement. The presence of immunological dysfunction in ASD has been well established. Aflatoxin B1 (AFB1 ) is a prevalent mycotoxin found in food and feed, causing immune toxicity and hepatotoxicity. AFB1 is significantly elevated in several regions around the globe. Existing research indicates that prolonged exposure to AFB1 results in neurological problems...
May 6, 2024: Journal of Neuroimmunology
journal
journal
28219
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.